Evidence map›Paper›PMID 28839354›Full record

ArticlePharmacognosy magazine

Quantification Analysis and

Sae-Rom Yoo, Soo-Jin Jeong, Na-Ri Lee, Hyeun-Kyoo Shin, Chang-Seob Seo

Open access · greenAbstract read
In one paragraph

Article in Pharmacognosy magazine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Effects and molecular mechanisms ofFrontiers in pharmacology · 2025
    Review
  5. Therapeutic potential of oleanolic acid in liver diseases.Naunyn-Schmiedeberg's archives of pharmacology · 2024
    Review
  6. Article
  7. Review
  8. Almond [Molecules (Basel, Switzerland) · 2023
    Article
  9. Novel SynthesizedInternational journal of molecular sciences · 2021
    Article
  10. Kochiae Fructus, the Fruit of Common PotherbEvidence-based complementary and alternative medicine : eCAM · 2021
    Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sae-Rom YooK-herb Research Center, Korea Institute of Oriental Medicine, Daejeon, Korea.
Soo-Jin JeongKM Convergence Research Division, Korea Institute of Oriental Medicine, Daejeon, Korea.
Na-Ri LeeK-herb Research Center, Korea Institute of Oriental Medicine, Daejeon, Korea.
Hyeun-Kyoo ShinK-herb Research Center, Korea Institute of Oriental Medicine, Daejeon, Korea.
Chang-Seob SeoK-herb Research Center, Korea Institute of Oriental Medicine, Daejeon, Korea.
Korea Institute of Oriental Medicine · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe fructus of

objectiveWe investigated the anti-inflammatory activities of three marker compounds, including 20-hydroxyecdysone, momordin Ic, and oleanolic acid, from the fructus of MATERIALS AND

methodsThe simultaneous analysis of three components was performed using high-performance liquid chromatography and high-performance thin-layer chromatography. We evaluated the anti-inflammatory effects of the nine marker compounds by determining their anti-inflammatory activities in the murine macrophage cell line RAW 264.7.

resultsAmong three marker compounds, momordin Ic, but not 20-hydroxyecdysone and oleanolic acid, had inhibitory effects on the production of inflammatory cytokines tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) in LPS-treated RAW264.7 macrophages. The effects of three marker compounds on prostaglandin E

conclusionsWe suggest that momordin Ic is the most potent phytochemical of the fructus of SUMMARY: Simultaneous analysis of three phenylpropanoids in the

Indexed as

20-hydroxyecdysoneAnti-inflammatory effectKochia scopariamomordin Icoleanolic acidRAW264.7

Identifiers

PMID28839354
PMCPMC5551347
OpenAlexW2738021802

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.